XEDEV

XEDEV is a CRO/CDMO specialised in formulation and process development for solid dosage forms. At XEDEV, we have the capabilities to develop early phase formulations for a very broad range of administration routes as well as formulation analyses by dedicated scientists to have a complete understanding of product quality and stability. XEDEV has a strong formulation and analytical development team, a GMP facility and an appropriate pharmaceutical quality system, enabling manufacturing up to phase IIb. Spray drying is one of our core strenghts. XEDEV follows a phase appropriate development approach for drug product development. Typically, a project is started within...

Contract development,spray drying,agglomeration,coating,prilling,scale-up,formulation,congealing,particle engineering,inhalation,taste masking,solubility enhancement,controlled release,clinical,gmp,process development,fluid bed,extrusion,and vacuum drying

Xedev operates in the Research services industry.

Xedev's revenue is 11m - 100m

Xedev has 11 - 50 employees.